Background: Systemic low-grade inflammation has been demonstrated in a range of the frequent noncommunicable diseases (NCDs) proposing a shared mechanism, but is largely unexplored in relation to allergic sensitization. We therefore aimed to investigate the possible association with childhood allergic sensitization. Methods: High-sensitivity C-reactive protein (hs-CRP), interleukin-1b (IL-1b), IL-6, tumor necrosis factor-a (TNF-a), and chemokine (C-X-C motif) ligand 8 (CXCL8) were measured in plasma at age 6 months (N = 214) and 7 years (N = 277) in children from the Copenhagen Prospective Studies on Asthma in Childhood 2000 (COPSAC 2000 ) birth cohort. Allergic sensitization against common inhalant and food allergens was determined longitudinally at ages ½, 1½, 4 and 6 years by specific IgE assessments and skin prick tests. Associations between inflammatory biomarkers and sensitization phenotypes were tested with logistic regression and principal component analyses (PCAs). Results: Adjusted for gender, recent infections, and a CRP genetic risk score, hs-CRP at 7 years was associated with concurrent elevated specific IgE against any allergen [adjusted OR (aOR) = 1.40; 95% CI, 1.14-1.72; P = 0.001], aeroallergens (aOR, 1.43; 1.15-1.77; P = 0.001), food allergens (aOR, 1.31; 95% CI, 1.02-1.67; P = 0.04), sensitization without any clinical allergy symptoms (aOR = 1.40; 1.06-1.85; P = 0.02), and with similar findings for skin prick tests. The other inflammatory markers were not univariately associated with sensitization, but multiparametric PCA suggested a specific inflammatory response among sensitized children. Inflammatory markers at age 6 months were not associated with subsequent development of sensitization phenotypes. Conclusions: Elevated hs-CRP is associated with allergic sensitization in schoolaged children suggesting systemic low-grade inflammation as a phenotypic characteristic of this early-onset NCD.
is reflected by elevated levels of C-reactive protein measured by high-sensitivity assays (hs-CRP) in highly endemic societies (4) and accompanying the specific disorders such as cardiovascular disease (5) , diabetes mellitus (6) , chronic obstructive pulmonary disease (7) , and asthma (8) . However, only very few studies have investigated whether childhood allergic sensitization is also characterized by systemic lowgrade inflammation.
The objective of this work was to investigate whether a systemic low-grade inflammatory process is present in young children with allergic sensitization based on data from the Copenhagen Prospective Studies on Asthma in Childhood 2000 (COPSAC 2000 ) birth cohort (9) . For that purpose, we measured plasma levels of hs-CRP along with secondary assessments of related inflammatory biomarkers including interleukin-6 (IL-6), IL-1b, tumor necrosis factor (TNF)-a, and chemokine (C-X-C motif) ligand 8 (CXCL8, formerly IL-8) at age 6 months and 7 years and investigated the possible association with allergic sensitization and rhinitis during preschool age.
Methods
The COPSAC 2000 
birth cohort
The participants comprised 411 children of the at-risk COP-SAC 2000 prospective birth cohort study born to mothers with physician-diagnosed asthma (9) . The children were enrolled at age 4 weeks and subsequently attended the COPSAC single-center clinical research unit for scheduled clinical investigations at 6-monthly intervals until age 7 years as well as immediately upon onset of any respiratory, allergy-, or skinrelated symptoms (10) (11) (12) . The pediatricians employed at the research unit acted as primary practitioners for the cohort children and were the only ones responsible for the diagnosis and treatment of asthma, allergy, and eczema in these children.
The study was conducted in accordance with the Declaration of Helsinki and was approved by the Local Ethics Committee (KF 01-289/96) and the Danish Data Protection Agency (2008-41-1754 ). Both parents gave oral and written informed consent before enrollment.
Inflammatory biomarkers
At age 6 months and 7 years, venous blood was sampled, centrifuged to separate plasma from cells, and immediately stored at À80°C until analysis. The samples were transported on dry ice to the laboratory, where levels of inflammatory biomarkers were determined by high-sensitivity ELISAs based on electrochemiluminescence in a 4-plex setting for IL1b, IL-6, CXCL8, and TNF-a and as a single high-sensitivity assay from MesoScale Discovery for hs-CRP. The lower limit of detection (LLOD) was 0.005 ng/ml. Samples were read in duplicate with the Sector Imager 6000 (MesoScale Discovery Ò , Gaithersburg, MD, USA). The limit of detection (mean signal from blanks + 3SD) was 9.54 pg/ml for hs-CRP, 0.15 pg/ml for IL-1b, 0.17 pg/ml for IL-6, 0.09 pg/ml for CXCL8, and 0.08 pg/ml for TNF-a.
We chose to investigate hs-CRP as this is a well-established measure of nonspecific low-grade inflammation in previous NCD studies (3) . The additional biomarkers were chosen to enable a biological validation of the hs-CRP levels as IL-6 triggers CRP release from the liver and should be associated with CRP, whereas CXCL8 is not directly related to CRP release.
Allergic sensitization
Allergic sensitization was assessed longitudinally at ages 6 months, 18 months, 4 years, and 6 years by specific IgE levels in serum and skin prick tests.
Specific IgE levels in serum were measured against 16 common inhalant and food allergens (cat, dog, horse, birch, timothy grass, mugwort, house dust mites, molds, hen's egg, cow's milk, fish, wheat, peanut, soybean, shrimp) by ImmunoCAP assay (Thermo Fisher Scientific, Uppsala, Sweden) (13) . Allergic sensitization was defined as specific IgE ≥ 0.35 kUa/l (14) .
Skin prick test was performed using standard allergen extracts (ALK-Abello, Soluprick Ò SQ, Hørsholm, Denmark) of 14 common allergens (cat, dog, horse, birch, timothy grass, mugwort, house dust mite, molds, egg, milk, fish, wheat, peanut, soybean) and with fresh cow's milk and pasteurized hen's egg (15) . Droplets of allergen extracts, fresh foods, and controls were applied to the child's volar forearm, and a sterile lancet was used to prick through the droplets penetrating the skin barrier. The reaction was noted after 15 min, and a positive test was defined as a wheal diameter ≥2 mm larger than the negative control (physiological sodium chloride, 9 mg/ml) at ages 6 and 18 months and ≥3 mm at ages 4 and 6 years. Children did not use antihistamines within 72 h of testing, mild steroid creams (groups 1-2) on the arms 24 h before testing, or stronger steroid creams (groups 3-4) 14 days before testing.
Allergic sensitization diagnosed from specific IgE or skin prick test was analyzed as sensitization to (i) any allergen, (ii) any aeroallergen, (iii) any food allergen, and (iv) any allergen without accompanying symptoms; that is, sensitization without asthma, rhinitis, food reactions, or eczema.
Allergic rhinitis
Allergic rhinitis was diagnosed at age 7 years by the COP-SAC pediatricians based on interviews with the parents on history of symptoms in the child's seventh year of life. Rhinitis was defined as troublesome sneezing or blocked or runny nose in the past 12 months in periods without concurrent cold or flu (16, 17) .
Total IgE
Total IgE level was measured at age 6 years by ImmunoCAP (Thermo Fisher Scientific) with a detection limit of 2 kU/l. 
Covariates
Covariates in relation to hs-CRP levels at age 7 years included gender; tobacco smoke exposure [parental smoking in the home at age 7 years (yes/no)]; yearly household income [low (<53 000 €), medium (53 000-80 000 €), high (>80 000 €)]; and infections 14 days prior to biomarker assessment [upper and lower respiratory tract infections, gastroenteritis, or fever with unknown cause (yes/no)]. Furthermore, a CRP genetic risk score was calculated based on 17 single nucleotide polymorphisms known to be related to CRP levels (18) with the score constructed as the sum of risk alleles weighted on their published effect size and subsequently transformed to z-scores (19) .
Statistics
Inflammatory biomarker values below detection limit were set to half of the lowest value detected for the specific biomarker. Values were log-transformed, and the mean of the duplicate measurements was used for association analyses.
Associations between continuous inflammatory biomarker levels and concurrent binary allergy outcomes were tested by conventional statistics with logistic regression, whereas the association with total IgE was analyzed by linear regression. The association between biomarker levels at age 6 months and subsequent development of allergy outcomes during preschool age was tested by logistic generalized estimating equations (GEE) utilizing the repeated subject assessments at all four age-points (6 months, 18 months, 4 years, and 6 years).
We also applied an unsupervised pattern recognition and dimensional reduction principal component analysis (PCA) for inflammatory biomarker levels at age 7 years. The PCA approach included extraction of underlying orthogonal components that described the systematic part of the variation across the biomarkers using centered and scaled mediator levels.
All results were presented as odds ratios with 95% CI. Analyses utilizing mediator levels at age 7 years were adjusted for covariates associated with levels of hs-CRP using a cutoff at P ≤ 0.10. Analyses utilizing mediator levels at age 6 months were adjusted for siblings, infections 14 days prior to mediator assessment, and wheeze at any time prior to mediator assessment, as we recently demonstrated an association between those covariates and hs-CRP at age 6 months in our cohort (20) . All analyses were carried out using SAS version 9.3 (SAS Institute, Cary, NC, USA).
Additional details are outlined in the Supporting information.
Results

Baseline characteristics
After completion of the 7-year follow-up, hs-CRP, IL-1b, IL-6, TNF-a, and CXCL8 were available for 277 (67%) of the 411 children in the cohort. Children with available biomarker assessments at age 7 years compared to children without assessments tended to come from families with higher household income (P = 0.06), but showed no other differences in baseline characteristics or asthma, allergy, or eczema prevalence (Table S1 ). Of the 277 children with mediator levels available at age 7 years, 214 also had levels measured at age 6 months.
Plasma levels of hs-CRP, IL-6, TNF-a, and CXCL8 were within the expected range at both age-points, whereas IL-1b levels were much lower than expected (21) with null values for 118 (43%) at age 7 years and 52 (24%) at age 6 months (Table S2) . Therefore, IL-1b was not included in the association analyses. IL-6 and hs-CRP levels were strongly positively correlated (P < 0.001), whereas TNF-a and CXCL8 levels were not significantly correlated with hs-CRP (P-values ≥ 0.32).
Determinants of hs-CRP at age 7 years
Girls had significantly higher hs-CRP levels compared to boys: median hs-CRP level 4.02 mg/l (IQR, 1.82-14.62) vs 1.92 mg/l (0.82-6.56), P = 0.0004; and hs-CRP was increased in children with an infectious episode within 14 days prior to biomarker assessment: 24.19 mg/l (4.32-33.51) vs 2.73 mg/l (1.16-7.50), P < 0.0001. Household income and tobacco smoke exposure in the home were not associated with hs-CRP levels (Table 1) . Based on these findings, we adjusted association analyses utilizing hs-CRP at age 7 years for gender and infections. 
CRP genetic risk score
The CRP genetic risk score was linearly associated with hs-CRP levels at 6 months (b-coefficient + 0.27 per z-score increase; 95% CI, 0.13-0.41; P = 0.0002) and hs-CRP levels at age 7 years (b-coefficient + 0.24 per z-score increase; 0.03-0.44; P = 0.02). Based on that, association analyses utilizing hs-CRP at age 6 months and 7 years were additionally adjusted for the CRP genetic risk score. However, the CRP risk score was not associated with the outcomes of interest, for example, any sensitization determined by specific IgE at age 7 years: OR, 0.97; 95% CI, 0.76-1.24; P = 0.82.
Inflammatory biomarkers at 7 years vs concurrent allergy endpoints
Specific IgE
High-sensitivity C-reactive protein was positively associated with presence of any sensitization [adjusted OR (aOR), 1.40; 1.14- (Table 2) . Median hs-CRP levels in children with and without rhinitis and the different sensitization phenotypes are depicted in Fig. 1 .
Asthma
Level of hs-CRP was also positively associated with an increased risk of current asthma: aOR, 1.37; 1.03-1.84; P = 0.03.
Total IgE
High-sensitivity C-reactive protein and total IgE levels were positively linearly associated: adjusted b-coefficient, 0.15; 0.03-0.26; P = 0.01. We found no univariate associations between IL-6, TNF-a, or CXCL8 levels and any of the above endpoints (Table 2) .
Unadjusted models revealed similar results and are shown in Table S3 . Furthermore, a sensitivity analysis excluding the 24 children with an infectious episode prior to the biomarker assessments showed comparable associations and significance levels (Table S4) .
Principal component analysis
An unsupervised multiparametric PCA showed that hs-CRP, IL-6, TNF-a, and CXCL8 at age 7 years were all positively correlated in the first principal component (PC 1 ) explaining 36% of the variation in the data, whereas 27% of the variation was explained by PC 2 , which separated hs-CRP and IL-6 from TNF-a and CXCL8 (Fig. 2) . PC 1 yielded increased odds ratios for all the allergic sensitization phenotypes, allergic rhinitis, and asthma, but the association was only statistically significant for asthma (P = 0.03). PC 2 was significantly associated with any positive skin prick test (P = 0.02) and allergic rhinitis (P = 0.03) and showed a trend of association with several of the other phenotypes (Table 3) .
Inflammatory biomarkers at 6 months vs development of allergy endpoints
We did not detect any relationship between hs-CRP, IL-6, TNF-a, or CXCL8 and concurrent allergic sensitization at age 6 months diagnosed from either sIgE (N = 22 cases) or skin prick test (N = 21 cases). Accordingly, a GEE model including sensitization data from ages 6 months, 18 months, 4 years, and 6 years did not show any associations between inflammatory biomarkers at age 6 months and subsequent development of sensitization phenotypes during preschool age (Table S5) .
Discussion
Principal findings
Allergic sensitization at school age is characterized by elevated hs-CRP level independently of allergen type or concurrent clinical allergy manifestations suggesting the presence of an active systemic inflammatory process in allergic sensitization similar to other NCDs. 
Strengths and limitations of the study
A major strength of this study is the comprehensive standardized objective assessments and clinical diagnoses performed solely by the research pediatricians at our singlecenter site in rigorous accordance with predefined algorithms. This approach allowed analyses of symptomatic and asymptomatic sensitization as well as analyses of different sensitization phenotypes. Consistent results across traditionally defined sensitization phenotypes and symptomatic vs nonsymptomatic sensitization enhance the confidence in the findings. Associations were most prominent for hs-CRP obtained both by conventional statistics and by the PCA approach, where PC 2 associated with sensitization and separated hs-CRP and IL-6 from TNF-a and CXCL8.
Another significant strength of the study is our ability to construct and adjust for a CRP genetic risk score (18) as some loci affect the development of asthma, sensitization, and CRP levels (22, 23) . The observed relationship between CRP levels and allergy-related outcomes could therefore be speculated to be due to pleiotropic gene effects and not the low-grade inflammation itself (24) . Our finding of a robust and unchanged association between sensitization and hs-CRP after adjusting for the CRP genetic risk score argues against pleiotropic gene effects being responsible for the association.
In line with previous studies, we found that hs-CRP was elevated in girls (25) , among patients with asthma (26), and in subjects with a recent infectious episode (27) , which serves as a biological validation of the data. Furthermore, hs-CRP levels were strongly linearly associated with IL-6, which is well known to trigger CRP release from the liver (28).
It is a limitation of the study that we could not detect a biologically meaningful signal from IL-1b, which may be caused by a prolonged storage time and previous freeze-thaw cycles of the samples. IL-1b is known to be particular sensitive to freeze-thawing and degrades significantly over time, even at À80°C (29).
We did not detect an association between passive smoke exposure and CRP at age 7 years, which could be related to a lack of an objective assessment such as urinary, salivary, or serum cotinine or nicotine levels at this age-point.
Another limitation of the study is the high-risk nature of the cohort, as all the children are born to mothers with a history of asthma, which reduces generalizability of the findings. However, even though the high risk of sensitization in the cohort may have influenced the measured biomarker levels, this should not diminish our ability to explore the association between allergic sensitization and biomarker levels within the cohort.
Interpretation of the findings
This study shows an association between increasing levels of hs-CRP and allergic sensitization in 7-year-old children suggesting that the propensity to develop elevated levels of specific IgE antibodies is a systemic low-grade inflammatory disorder.
Elevated hs-CRP was present in children with allergic sensitization irrespective of allergen type or combination of specific sensitizations and thus not a specific characteristic of food or aeroallergen sensitization. This implies that lowgrade inflammation in children with allergic sensitization is a common host feature rather than a disease-specific trait. Such interpretation is supported by the association between hs-CRP and specific IgE levels even in asymptomatic children and the association with total IgE suggesting that low-grade inflammation may characterize children with poor immune regulation rather than children with symptomatic vs asymptomatic disease. Unfortunately, the lack of association between low-grade inflammation at age 6 months and subsequent development of sensitization implies that hs-CRP cannot be utilized as a predictive biomarker.
In line with our findings, specific IgE data from 2-to 19-year-old children and adolescents (N = 4111) participating in the 2005-2006 US National Health and Nutrition Examination Survey (NHANES) showed elevated hs-CRP in subjects with allergic sensitization (30) . In contrast, another study of 131 children aged 6-18 years did not detect such association, but all the children had current asthma and were recruited from a tertiary pulmonary center (31) , which may have impacted the analyses. The European multinational PAS-TURE (Protection against Allergy Study in Rural Environments) study group reported an inverse association between hs-CRP at age 1 year and allergic sensitization at age 4½ years among 636 children (32). We could not detect an association between hs-CRP levels at age 6 months and subsequent development of sensitization during preschool age, but comparability between our and the PASTURE study findings is limited as half of the population in the PASTURE study is from farming environments, which may affect both the level of low-grade inflammation and risk of sensitization. Besides these three The observed association between hs-CRP and sensitization may be interpreted as allergic sensitization being a systemic inflammatory disorder rather than an isolated T-helper 2-driven immune response. In support of this theory, cytokines and chemokines originating from the allergic cascade have been shown to trigger recruitment of inflammatory progenitor cells from the bone marrow as a possible systemic immune-inflammatory pathway (33) . Local production of IL-6 and TNF-a triggering CRP release from the liver or possibly IL-1b-related inflammasome activation in tissue macrophages could also contribute to sustained elevation of CRP and low-grade inflammation, as CRP is not cleared by binding to phosphocholine on microbes in the absence of an infection. Alternatively, systemic low-grade inflammation is not per se part of the allergic sensitization immune phenotype, but is indirectly linked to sensitization through shared environmental risk factors such as alterations of the human microbiome (34, 35) and changing dietary habits (36) .
A vicious cycle of sustained low-grade inflammation with elevated hs-CRP has now been demonstrated in NCDs emerging from virtually all organ systems (1) proposing an active inflammatory process as a common nominator of such disorders. This suggests a central role of the immune system not only in childhood allergic sensitization, but also in many other idiopathic immuno-inflammatory disorders which have increased in prevalence along with the global adaption of modern environmental and lifestyle changes (37) . Strategies to restore the early-life immunological health status, such as high-dose vitamin D supplementation during pregnancy (38), may thus not only have the capacity to prevent development of allergic sensitization but potentially also prevent a range of other frequent NCDs warranting increased awareness of childhood allergy in future NCD research.
Conclusion
Allergic sensitization in school-aged children of the Danish COPSAC 2000 at-risk birth cohort is associated with elevated hs-CRP suggesting systemic low-grade inflammation as a phenotypic characteristic of childhood sensitization.
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